Clearbridge Investments, LLC Myriad Genetics Inc Transaction History

Clearbridge Investments, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$10.69 - $16.49 $14,709 - $22,690	-1,376 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $391 - $1,181	-40 Reduced 2.82%	1,376 $20,000
Q4 2019 Feb 14, 2020	SELL	$20.93 - $35.1 $20 - $35	-1 Reduced 0.07%	1,416 $39,000
Q3 2019 Nov 14, 2019	SELL	$22.08 - $47.08 $331 - $706	-15 Reduced 1.05%	1,417 $41,000
Q2 2019 Aug 14, 2019	SELL	$22.67 - $35.0 $113 - $175	-5 Reduced 0.35%	1,432 $0
Q1 2019 May 15, 2019	SELL	$26.93 - $34.7 $188 - $242	-7 Reduced 0.48%	1,437 $48,000
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $517 - $865	19 Added 1.33%	1,444 $42,000
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $187 - $251	-5 Reduced 0.35%	1,425 $66,000
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $194 - $281	-7 Reduced 0.49%	1,430 $53,000
Q4 2017 Feb 14, 2018	BUY	$28.45 - $37.14 $142 - $185	5 Added 0.35%	1,437 $49,000
Q3 2017 Nov 14, 2017	BUY	$24.01 - $36.2 $1,032 - $1,556	43 Added 3.1%	1,432 $52,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,389	1,389 $36,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.